A fatal course of COVID-19 during the Omicron surge : can you estimate your patients' SARS-CoV-2 immune status?
© 2023. The Author(s)..
We present a case of an ultimately fatal course of COVID-19 (coronavirus disease-19) in an 81-year-old female patient during the Omicron surge. The patient did not represent the typical patient at risk for severe COVID-19 with significant causes of immunodeficiency. However, she had been skeptical about the vaccination for severe acute respiratory syndrome virus-2 (SARS-CoV-2) and had refused it. Moreover, there had been no previous COVID-19 episodes. Our case report illustrates that with regard to SARS-CoV-2, immunologically naive patients are still at risk for severe and/or even fatal courses of COVID-19. We call to implement both, recommendations for SARS-CoV-2 vaccinations as well as for antiviral treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Infection - 52(2024), 1 vom: 25. Feb., Seite 271-273 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mersch, Martin [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 26.01.2024 Date Revised 07.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s15010-023-02120-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364243325 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364243325 | ||
003 | DE-627 | ||
005 | 20240307232040.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s15010-023-02120-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1319.xml |
035 | |a (DE-627)NLM364243325 | ||
035 | |a (NLM)37932523 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mersch, Martin |e verfasserin |4 aut | |
245 | 1 | 2 | |a A fatal course of COVID-19 during the Omicron surge |b can you estimate your patients' SARS-CoV-2 immune status? |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.01.2024 | ||
500 | |a Date Revised 07.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a We present a case of an ultimately fatal course of COVID-19 (coronavirus disease-19) in an 81-year-old female patient during the Omicron surge. The patient did not represent the typical patient at risk for severe COVID-19 with significant causes of immunodeficiency. However, she had been skeptical about the vaccination for severe acute respiratory syndrome virus-2 (SARS-CoV-2) and had refused it. Moreover, there had been no previous COVID-19 episodes. Our case report illustrates that with regard to SARS-CoV-2, immunologically naive patients are still at risk for severe and/or even fatal courses of COVID-19. We call to implement both, recommendations for SARS-CoV-2 vaccinations as well as for antiviral treatment | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Immune status | |
650 | 4 | |a Omicron variant of concern | |
650 | 4 | |a Severe course | |
700 | 1 | |a Schlabe, Stefan |e verfasserin |4 aut | |
700 | 1 | |a Breitschwerdt, Sven |e verfasserin |4 aut | |
700 | 1 | |a Laufenberg, Judith |e verfasserin |4 aut | |
700 | 1 | |a Emmert, Dorian |e verfasserin |4 aut | |
700 | 1 | |a Aldabbagh, Souhaib |e verfasserin |4 aut | |
700 | 1 | |a Boesecke, Christoph |e verfasserin |4 aut | |
700 | 1 | |a Monin, Malte Benedikt |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infection |d 1973 |g 52(2024), 1 vom: 25. Feb., Seite 271-273 |w (DE-627)NLM00001740X |x 1439-0973 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2024 |g number:1 |g day:25 |g month:02 |g pages:271-273 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s15010-023-02120-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2024 |e 1 |b 25 |c 02 |h 271-273 |